Puma Biotechnology, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue44.8M75.5M54.5M52.4M46.0M59.1M80.5M47.1M
Cost of Goods Sold10.4M23.1M12.2M12.3M10.6M13.9M29.1M10.7M
Gross Profit34.4M52.3M42.3M40.1M35.5M45.2M51.4M36.4M
R&D Expenses19.8M16.8M15.9M15.5M13.9M15.2M12.5M13.6M
Operating Expenses38.2M35.2M32.7M33.5M31.5M31.8M29.4M38.6M
Operating Income-3.8M17.1M9.6M6.6M4.0M13.4M22.1M-2.2M
Other Income / Gains401K1K-330K-471K-717K-1.1M-1.5M-2.0M
Net Income-3.8M13.4M8.8M5.9M3.0M19.3M20.3M-4.5M
EPS (Diluted)-0.0740.270.180.120.060.390.41-0.094
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7670.6930.7770.7650.7710.7640.6390.774
General And Administrative Expenses18.4M18.4M17.0M18.4M17.4M17.0M16.9M25.2M
Selling And Marketing Expenses0000000-183K
Selling General And Administrative Expenses18.4M18.4M17.0M18.4M17.4M17.0M16.9M25.0M
Other Expenses00-213K-362K213K-398K-48K0
Cost And Expenses48.6M58.3M44.9M45.8M42.0M45.7M58.5M49.3M
Interest Income1.0M977K1.0M956K1.1M1.2M1.3M1.2M
Interest Expense731K1.1M1.5M1.8M2.2M2.6M3.1M3.4M
Depreciation And Amortization2.5M2.7M2.7M2.8M2.8M2.8M2.9M2.9M
Ebitda-196K20.9M13.5M10.8M8.2M17.7M26.6M2.1M
Ebitdaratio-0.0040.2770.2470.2050.1790.300.330.045
Operating Income Ratio-0.0850.2270.1760.1270.0870.2260.274-0.046
Income Before Tax-3.4M17.1M9.2M6.2M3.3M12.2M20.6M-4.2M
Income Before Tax Ratio-0.0760.2270.170.1180.0710.2070.256-0.088
Income Tax Expense326K3.7M399K310K293K-7.1M291K378K
Net Income Ratio-0.0840.1780.1620.1120.0650.3270.252-0.096
Epsdiluted-0.0740.260.170.120.060.390.41-0.094
Weighted Average Shs Out50.8M50.3M50.3M49.7M49.6M49.1M49.0M48.3M
Weighted Average Shs Out Dil50.8M51.5M50.9M50.1M49.9M49.4M49.2M48.3M